Pharma & Healthcare
Global Embolization Particle Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301393
- Pages: 139
- Figures: 139
- Views: 1
In 2024, the global market size of Embolization Particle was estimated to be worth US$ 2633 million and is forecast to reach approximately US$ 6708 million by 2031 with a CAGR of 14.5% during the forecast period 2025-2031.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Embolization Particle in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolization Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.
The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolization Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolization Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Embolization Particle in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Embolization Particle Product Introduction
1.2 Market by Type
1.2.1 Global Embolization Particle Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market by Application
1.3.1 Global Embolization Particle Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Embolization Particle Market Size Estimates and Forecasts
2.1.1 Global Embolization Particle Revenue 2020-2031
2.1.2 Global Embolization Particle Sales 2020-2031
2.2 Embolization Particle Market Size by Region: 2024 Versus 2031
2.3 Embolization Particle Sales by Region (2020-2031)
2.3.1 Global Embolization Particle Sales by Region: 2020-2025
2.3.2 Global Embolization Particle Sales Forecast by Region (2026-2031)
2.3.3 Global Embolization Particle Sales Market Share by Region (2020-2031)
2.4 Embolization Particle Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Embolization Particle Revenue by Region: 2020-2025
2.4.2 Global Embolization Particle Revenue Forecast by Region (2026-2031)
2.4.3 Global Embolization Particle Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Embolization Particle Sales by Type (2020-2031)
3.1.1.1 Global Embolization Particle Sales Volume by Type (2020-2031)
3.1.1.2 Global Embolization Particle Sales Market Share by Type (2020-2031)
3.1.2 Global Embolization Particle Revenue by Type (2020-2031)
3.1.2.1 Global Embolization Particle Revenue by Type (2020-2031)
3.1.2.2 Global Embolization Particle Revenue Market Share by Type (2020-2031)
3.1.3 Embolization Particle Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Embolization Particle Sales by Application (2020-2031)
3.2.1.1 Global Embolization Particle Sales Volume by Application (2020-2031)
3.2.1.2 Global Embolization Particle Sales Market Share by Application (2020-2031)
3.2.2 Global Embolization Particle Revenue by Application (2020-2031)
3.2.2.1 Global Embolization Particle Revenue by Application (2020-2031)
3.2.2.2 Global Embolization Particle Revenue Market Share by Application (2020-2031)
3.2.3 Embolization Particle Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Microspheres of Embolization Particle Revenue Market Share by Application
3.3.2 Particles (e.g. PVA Particles, Gelfoam Particles) of Embolization Particle Revenue Market Share by Application
3.3.3 Drug-eluting Beads (DEBs) of Embolization Particle Revenue Market Share by Application
3.3.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) of Embolization Particle Revenue Market Share by Application
4 Global Embolization Particle by Manufacturers
4.1 Global Top Embolization Particle Manufacturers by Sales (2020-2025)
4.1.1 Global Embolization Particle Sales by Manufacturer (2020-2025)
4.1.2 Global Embolization Particle Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Embolization Particle Manufacturers by Revenue (2020-2025)
4.2.1 Global Embolization Particle Revenue by Manufacturer (2020-2025)
4.2.2 Global Embolization Particle Revenue Share by Manufacturer (2020-2025)
4.3 Global Embolization Particle Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Embolization Particle Manufacturers Covered: Ranking by Revenue
4.4.2 Global Embolization Particle Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Embolization Particle Manufacturing Base Distribution, Product Type
4.5.1 Embolization Particle Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Embolization Particle Market
4.5.3 Manufacturers Embolization Particle Product Type and Application
4.5.4 Microspheres Market Sales of Embolization Particle by Manufacturer
4.5.5 Particles (e.g. PVA Particles, Gelfoam Particles) Market Sales of Embolization Particle by Manufacturer
4.5.6 Drug-eluting Beads (DEBs) Market Sales of Embolization Particle by Manufacturer
4.5.7 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Sales of Embolization Particle by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sirtex Medical
5.1.1 Sirtex Medical Company Information
5.1.2 Sirtex Medical Description, Business Overview
5.1.3 Sirtex Medical Embolization Particle Products Offered
5.1.4 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sirtex Medical Embolization Particle Sales by Product in 2024
5.1.6 Sirtex Medical Embolization Particle Sales by Application in 2024
5.1.7 Sirtex Medical Embolization Particle Sales by Geographic Area in 2024
5.1.8 Sirtex Medical Recent Developments
5.2 Merit Medical
5.2.1 Merit Medical Company Information
5.2.2 Merit Medical Description, Business Overview
5.2.3 Merit Medical Embolization Particle Products Offered
5.2.4 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merit Medical Embolization Particle Sales by Product in 2024
5.2.6 Merit Medical Embolization Particle Sales by Application in 2024
5.2.7 Merit Medical Embolization Particle Sales by Geographic Area in 2024
5.2.8 Merit Medical Recent Developments
5.3 Cook Medical
5.3.1 Cook Medical Company Information
5.3.2 Cook Medical Description, Business Overview
5.3.3 Cook Medical Embolization Particle Products Offered
5.3.4 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cook Medical Embolization Particle Sales by Product in 2024
5.3.6 Cook Medical Embolization Particle Sales by Application in 2024
5.3.7 Cook Medical Embolization Particle Sales by Geographic Area in 2024
5.3.8 Cook Medical Recent Developments
5.4 BTG Medical
5.4.1 BTG Medical Company Information
5.4.2 BTG Medical Description, Business Overview
5.4.3 BTG Medical Embolization Particle Products Offered
5.4.4 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BTG Medical Embolization Particle Sales by Product in 2024
5.4.6 BTG Medical Embolization Particle Sales by Application in 2024
5.4.7 BTG Medical Embolization Particle Sales by Geographic Area in 2024
5.4.8 BTG Medical Recent Developments
5.5 Boston Scientific Corporation
5.5.1 Boston Scientific Corporation Company Information
5.5.2 Boston Scientific Corporation Description, Business Overview
5.5.3 Boston Scientific Corporation Embolization Particle Products Offered
5.5.4 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Boston Scientific Corporation Embolization Particle Sales by Product in 2024
5.5.6 Boston Scientific Corporation Embolization Particle Sales by Application in 2024
5.5.7 Boston Scientific Corporation Embolization Particle Sales by Geographic Area in 2024
5.5.8 Boston Scientific Corporation Recent Developments
5.6 Terumo Corporation
5.6.1 Terumo Corporation Company Information
5.6.2 Terumo Corporation Description, Business Overview
5.6.3 Terumo Corporation Embolization Particle Products Offered
5.6.4 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Terumo Corporation Embolization Particle Sales by Product in 2024
5.6.6 Terumo Corporation Embolization Particle Sales by Application in 2024
5.6.7 Terumo Corporation Embolization Particle Sales by Geographic Area in 2024
5.6.8 Terumo Corporation Recent Developments
5.7 HENGRUI Medical
5.7.1 HENGRUI Medical Company Information
5.7.2 HENGRUI Medical Description, Business Overview
5.7.3 HENGRUI Medical Embolization Particle Products Offered
5.7.4 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.7.5 HENGRUI Medical Embolization Particle Sales by Product in 2024
5.7.6 HENGRUI Medical Embolization Particle Sales by Application in 2024
5.7.7 HENGRUI Medical Embolization Particle Sales by Geographic Area in 2024
5.7.8 HENGRUI Medical Recent Developments
5.8 INterface BIOmaterials B.V.
5.8.1 INterface BIOmaterials B.V. Company Information
5.8.2 INterface BIOmaterials B.V. Description, Business Overview
5.8.3 INterface BIOmaterials B.V. Embolization Particle Products Offered
5.8.4 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.8.5 INterface BIOmaterials B.V. Embolization Particle Sales by Product in 2024
5.8.6 INterface BIOmaterials B.V. Embolization Particle Sales by Application in 2024
5.8.7 INterface BIOmaterials B.V. Embolization Particle Sales by Geographic Area in 2024
5.8.8 INterface BIOmaterials B.V. Recent Developments
5.9 Alicon
5.9.1 Alicon Company Information
5.9.2 Alicon Description, Business Overview
5.9.3 Alicon Embolization Particle Products Offered
5.9.4 Alicon Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Alicon Embolization Particle Sales by Product in 2024
5.9.6 Alicon Embolization Particle Sales by Application in 2024
5.9.7 Alicon Embolization Particle Sales by Geographic Area in 2024
5.9.8 Alicon Recent Developments
6 North America
6.1 North America Embolization Particle Market Size YoY Growth 2020-2031
6.2 North America Embolization Particle Market Facts & Figures by Country
6.2.1 North America Embolization Particle Sales by Country (2020-2031)
6.2.2 North America Embolization Particle Revenue by Country (2020-2031)
6.3 North America Embolization Particle Sales by Type (2020-2025)
6.4 North America Embolization Particle Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Embolization Particle Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Embolization Particle Market Facts & Figures by Region
7.2.1 Asia-Pacific Embolization Particle Sales by Region (2020-2031)
7.2.2 Asia-Pacific Embolization Particle Revenue by Region (2020-2031)
7.3 Asia-Pacific Embolization Particle Sales by Type (2020-2025)
7.4 Asia-Pacific Embolization Particle Sales by Application (2020-2025)
8 Europe
8.1 Europe Embolization Particle Market Size YoY Growth 2020-2031
8.2 Europe Embolization Particle Market Facts & Figures by Country
8.2.1 Europe Embolization Particle Sales by Country (2020-2031)
8.2.2 Europe Embolization Particle Revenue by Country (2020-2031)
8.3 Europe Embolization Particle Sales by Type (2020-2025)
8.4 Europe Embolization Particle Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Embolization Particle Market Size YoY Growth 2020-2031
9.2 Latin America Embolization Particle Market Facts & Figures by Country
9.2.1 Latin America Embolization Particle Sales by Country (2020-2031)
9.2.2 Latin America Embolization Particle Revenue by Country (2020-2031)
9.3 Latin America Embolization Particle Sales by Type (2020-2025)
9.4 Latin America Embolization Particle Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Embolization Particle Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Embolization Particle Market Facts & Figures by Country
10.2.1 Middle East and Africa Embolization Particle Sales by Country (2020-2031)
10.2.2 Middle East and Africa Embolization Particle Revenue by Country (2020-2031)
10.3 Middle East and Africa Embolization Particle Sales by Type (2020-2025)
10.4 Middle East and Africa Embolization Particle Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Embolization Particle Supply Chain Analysis
11.2 Embolization Particle Key Raw Materials and Upstream Suppliers
11.3 Embolization Particle Clients Analysis
11.4 Embolization Particle Sales Channel and Sales Model Analysis
11.4.1 Embolization Particle Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Embolization Particle Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Embolization Particle Distributors
12 Embolization Particle Market Dynamics
12.1 Embolization Particle Industry Trends
12.2 Embolization Particle Market Drivers
12.3 Embolization Particle Market Challenges
12.4 Embolization Particle Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Embolization Particle Product Introduction
1.2 Market by Type
1.2.1 Global Embolization Particle Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market by Application
1.3.1 Global Embolization Particle Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Embolization Particle Market Size Estimates and Forecasts
2.1.1 Global Embolization Particle Revenue 2020-2031
2.1.2 Global Embolization Particle Sales 2020-2031
2.2 Embolization Particle Market Size by Region: 2024 Versus 2031
2.3 Embolization Particle Sales by Region (2020-2031)
2.3.1 Global Embolization Particle Sales by Region: 2020-2025
2.3.2 Global Embolization Particle Sales Forecast by Region (2026-2031)
2.3.3 Global Embolization Particle Sales Market Share by Region (2020-2031)
2.4 Embolization Particle Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Embolization Particle Revenue by Region: 2020-2025
2.4.2 Global Embolization Particle Revenue Forecast by Region (2026-2031)
2.4.3 Global Embolization Particle Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Embolization Particle Sales by Type (2020-2031)
3.1.1.1 Global Embolization Particle Sales Volume by Type (2020-2031)
3.1.1.2 Global Embolization Particle Sales Market Share by Type (2020-2031)
3.1.2 Global Embolization Particle Revenue by Type (2020-2031)
3.1.2.1 Global Embolization Particle Revenue by Type (2020-2031)
3.1.2.2 Global Embolization Particle Revenue Market Share by Type (2020-2031)
3.1.3 Embolization Particle Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Embolization Particle Sales by Application (2020-2031)
3.2.1.1 Global Embolization Particle Sales Volume by Application (2020-2031)
3.2.1.2 Global Embolization Particle Sales Market Share by Application (2020-2031)
3.2.2 Global Embolization Particle Revenue by Application (2020-2031)
3.2.2.1 Global Embolization Particle Revenue by Application (2020-2031)
3.2.2.2 Global Embolization Particle Revenue Market Share by Application (2020-2031)
3.2.3 Embolization Particle Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Microspheres of Embolization Particle Revenue Market Share by Application
3.3.2 Particles (e.g. PVA Particles, Gelfoam Particles) of Embolization Particle Revenue Market Share by Application
3.3.3 Drug-eluting Beads (DEBs) of Embolization Particle Revenue Market Share by Application
3.3.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) of Embolization Particle Revenue Market Share by Application
4 Global Embolization Particle by Manufacturers
4.1 Global Top Embolization Particle Manufacturers by Sales (2020-2025)
4.1.1 Global Embolization Particle Sales by Manufacturer (2020-2025)
4.1.2 Global Embolization Particle Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Embolization Particle Manufacturers by Revenue (2020-2025)
4.2.1 Global Embolization Particle Revenue by Manufacturer (2020-2025)
4.2.2 Global Embolization Particle Revenue Share by Manufacturer (2020-2025)
4.3 Global Embolization Particle Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Embolization Particle Manufacturers Covered: Ranking by Revenue
4.4.2 Global Embolization Particle Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Embolization Particle Manufacturing Base Distribution, Product Type
4.5.1 Embolization Particle Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Embolization Particle Market
4.5.3 Manufacturers Embolization Particle Product Type and Application
4.5.4 Microspheres Market Sales of Embolization Particle by Manufacturer
4.5.5 Particles (e.g. PVA Particles, Gelfoam Particles) Market Sales of Embolization Particle by Manufacturer
4.5.6 Drug-eluting Beads (DEBs) Market Sales of Embolization Particle by Manufacturer
4.5.7 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Sales of Embolization Particle by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sirtex Medical
5.1.1 Sirtex Medical Company Information
5.1.2 Sirtex Medical Description, Business Overview
5.1.3 Sirtex Medical Embolization Particle Products Offered
5.1.4 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sirtex Medical Embolization Particle Sales by Product in 2024
5.1.6 Sirtex Medical Embolization Particle Sales by Application in 2024
5.1.7 Sirtex Medical Embolization Particle Sales by Geographic Area in 2024
5.1.8 Sirtex Medical Recent Developments
5.2 Merit Medical
5.2.1 Merit Medical Company Information
5.2.2 Merit Medical Description, Business Overview
5.2.3 Merit Medical Embolization Particle Products Offered
5.2.4 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merit Medical Embolization Particle Sales by Product in 2024
5.2.6 Merit Medical Embolization Particle Sales by Application in 2024
5.2.7 Merit Medical Embolization Particle Sales by Geographic Area in 2024
5.2.8 Merit Medical Recent Developments
5.3 Cook Medical
5.3.1 Cook Medical Company Information
5.3.2 Cook Medical Description, Business Overview
5.3.3 Cook Medical Embolization Particle Products Offered
5.3.4 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Cook Medical Embolization Particle Sales by Product in 2024
5.3.6 Cook Medical Embolization Particle Sales by Application in 2024
5.3.7 Cook Medical Embolization Particle Sales by Geographic Area in 2024
5.3.8 Cook Medical Recent Developments
5.4 BTG Medical
5.4.1 BTG Medical Company Information
5.4.2 BTG Medical Description, Business Overview
5.4.3 BTG Medical Embolization Particle Products Offered
5.4.4 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BTG Medical Embolization Particle Sales by Product in 2024
5.4.6 BTG Medical Embolization Particle Sales by Application in 2024
5.4.7 BTG Medical Embolization Particle Sales by Geographic Area in 2024
5.4.8 BTG Medical Recent Developments
5.5 Boston Scientific Corporation
5.5.1 Boston Scientific Corporation Company Information
5.5.2 Boston Scientific Corporation Description, Business Overview
5.5.3 Boston Scientific Corporation Embolization Particle Products Offered
5.5.4 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Boston Scientific Corporation Embolization Particle Sales by Product in 2024
5.5.6 Boston Scientific Corporation Embolization Particle Sales by Application in 2024
5.5.7 Boston Scientific Corporation Embolization Particle Sales by Geographic Area in 2024
5.5.8 Boston Scientific Corporation Recent Developments
5.6 Terumo Corporation
5.6.1 Terumo Corporation Company Information
5.6.2 Terumo Corporation Description, Business Overview
5.6.3 Terumo Corporation Embolization Particle Products Offered
5.6.4 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Terumo Corporation Embolization Particle Sales by Product in 2024
5.6.6 Terumo Corporation Embolization Particle Sales by Application in 2024
5.6.7 Terumo Corporation Embolization Particle Sales by Geographic Area in 2024
5.6.8 Terumo Corporation Recent Developments
5.7 HENGRUI Medical
5.7.1 HENGRUI Medical Company Information
5.7.2 HENGRUI Medical Description, Business Overview
5.7.3 HENGRUI Medical Embolization Particle Products Offered
5.7.4 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.7.5 HENGRUI Medical Embolization Particle Sales by Product in 2024
5.7.6 HENGRUI Medical Embolization Particle Sales by Application in 2024
5.7.7 HENGRUI Medical Embolization Particle Sales by Geographic Area in 2024
5.7.8 HENGRUI Medical Recent Developments
5.8 INterface BIOmaterials B.V.
5.8.1 INterface BIOmaterials B.V. Company Information
5.8.2 INterface BIOmaterials B.V. Description, Business Overview
5.8.3 INterface BIOmaterials B.V. Embolization Particle Products Offered
5.8.4 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.8.5 INterface BIOmaterials B.V. Embolization Particle Sales by Product in 2024
5.8.6 INterface BIOmaterials B.V. Embolization Particle Sales by Application in 2024
5.8.7 INterface BIOmaterials B.V. Embolization Particle Sales by Geographic Area in 2024
5.8.8 INterface BIOmaterials B.V. Recent Developments
5.9 Alicon
5.9.1 Alicon Company Information
5.9.2 Alicon Description, Business Overview
5.9.3 Alicon Embolization Particle Products Offered
5.9.4 Alicon Embolization Particle Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Alicon Embolization Particle Sales by Product in 2024
5.9.6 Alicon Embolization Particle Sales by Application in 2024
5.9.7 Alicon Embolization Particle Sales by Geographic Area in 2024
5.9.8 Alicon Recent Developments
6 North America
6.1 North America Embolization Particle Market Size YoY Growth 2020-2031
6.2 North America Embolization Particle Market Facts & Figures by Country
6.2.1 North America Embolization Particle Sales by Country (2020-2031)
6.2.2 North America Embolization Particle Revenue by Country (2020-2031)
6.3 North America Embolization Particle Sales by Type (2020-2025)
6.4 North America Embolization Particle Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Embolization Particle Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Embolization Particle Market Facts & Figures by Region
7.2.1 Asia-Pacific Embolization Particle Sales by Region (2020-2031)
7.2.2 Asia-Pacific Embolization Particle Revenue by Region (2020-2031)
7.3 Asia-Pacific Embolization Particle Sales by Type (2020-2025)
7.4 Asia-Pacific Embolization Particle Sales by Application (2020-2025)
8 Europe
8.1 Europe Embolization Particle Market Size YoY Growth 2020-2031
8.2 Europe Embolization Particle Market Facts & Figures by Country
8.2.1 Europe Embolization Particle Sales by Country (2020-2031)
8.2.2 Europe Embolization Particle Revenue by Country (2020-2031)
8.3 Europe Embolization Particle Sales by Type (2020-2025)
8.4 Europe Embolization Particle Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Embolization Particle Market Size YoY Growth 2020-2031
9.2 Latin America Embolization Particle Market Facts & Figures by Country
9.2.1 Latin America Embolization Particle Sales by Country (2020-2031)
9.2.2 Latin America Embolization Particle Revenue by Country (2020-2031)
9.3 Latin America Embolization Particle Sales by Type (2020-2025)
9.4 Latin America Embolization Particle Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Embolization Particle Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Embolization Particle Market Facts & Figures by Country
10.2.1 Middle East and Africa Embolization Particle Sales by Country (2020-2031)
10.2.2 Middle East and Africa Embolization Particle Revenue by Country (2020-2031)
10.3 Middle East and Africa Embolization Particle Sales by Type (2020-2025)
10.4 Middle East and Africa Embolization Particle Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Embolization Particle Supply Chain Analysis
11.2 Embolization Particle Key Raw Materials and Upstream Suppliers
11.3 Embolization Particle Clients Analysis
11.4 Embolization Particle Sales Channel and Sales Model Analysis
11.4.1 Embolization Particle Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Embolization Particle Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Embolization Particle Distributors
12 Embolization Particle Market Dynamics
12.1 Embolization Particle Industry Trends
12.2 Embolization Particle Market Drivers
12.3 Embolization Particle Market Challenges
12.4 Embolization Particle Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Embolization Particle Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Embolization Particle Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Embolization Particle Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Embolization Particle Sales by Region (2020-2025) & (K Units)
Table 5. Global Embolization Particle Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Embolization Particle Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Embolization Particle Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Embolization Particle Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Embolization Particle Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Embolization Particle Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Embolization Particle Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Embolization Particle Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Embolization Particle Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Embolization Particle Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Embolization Particle Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Embolization Particle Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Embolization Particle Sales Share by Manufacturer (2020-2025)
Table 18. Embolization Particle Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Embolization Particle Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Embolization Particle Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Embolization Particle Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Embolization Particle Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2024)
Table 24. Embolization Particle Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Embolization Particle Market
Table 26. Manufacturers Embolization Particle Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Sirtex Medical Company Information
Table 29. Sirtex Medical Description and Business Overview
Table 30. Sirtex Medical Embolization Particle Product
Table 31. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Sirtex Medical Sales Proportion of Embolization Particle by Product in 2024
Table 33. Sirtex Medical Sales Proportion of Embolization Particle by Application in 2024
Table 34. Sirtex Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 35. Sirtex Medical Recent Developments
Table 36. Merit Medical Company Information
Table 37. Merit Medical Description and Business Overview
Table 38. Merit Medical Embolization Particle Product
Table 39. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merit Medical Sales Proportion of Embolization Particle by Product in 2024
Table 41. Merit Medical Sales Proportion of Embolization Particle by Application in 2024
Table 42. Merit Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 43. Merit Medical Recent Developments
Table 44. Cook Medical Company Information
Table 45. Cook Medical Description and Business Overview
Table 46. Cook Medical Embolization Particle Product
Table 47. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Cook Medical Sales Proportion of Embolization Particle by Product in 2024
Table 49. Cook Medical Sales Proportion of Embolization Particle by Application in 2024
Table 50. Cook Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 51. Cook Medical Recent Developments
Table 52. BTG Medical Company Information
Table 53. BTG Medical Description and Business Overview
Table 54. BTG Medical Embolization Particle Product
Table 55. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. BTG Medical Sales Proportion of Embolization Particle by Product in 2024
Table 57. BTG Medical Sales Proportion of Embolization Particle by Application in 2024
Table 58. BTG Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 59. BTG Medical Recent Developments
Table 60. Boston Scientific Corporation Company Information
Table 61. Boston Scientific Corporation Description and Business Overview
Table 62. Boston Scientific Corporation Embolization Particle Product
Table 63. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Boston Scientific Corporation Sales Proportion of Embolization Particle by Product in 2024
Table 65. Boston Scientific Corporation Sales Proportion of Embolization Particle by Application in 2024
Table 66. Boston Scientific Corporation Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 67. Boston Scientific Corporation Recent Developments
Table 68. Terumo Corporation Company Information
Table 69. Terumo Corporation Description and Business Overview
Table 70. Terumo Corporation Embolization Particle Product
Table 71. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Terumo Corporation Sales Proportion of Embolization Particle by Product in 2024
Table 73. Terumo Corporation Sales Proportion of Embolization Particle by Application in 2024
Table 74. Terumo Corporation Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 75. Terumo Corporation Recent Developments
Table 76. HENGRUI Medical Company Information
Table 77. HENGRUI Medical Description and Business Overview
Table 78. HENGRUI Medical Embolization Particle Product
Table 79. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. HENGRUI Medical Sales Proportion of Embolization Particle by Product in 2024
Table 81. HENGRUI Medical Sales Proportion of Embolization Particle by Application in 2024
Table 82. HENGRUI Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 83. HENGRUI Medical Recent Developments
Table 84. INterface BIOmaterials B.V. Company Information
Table 85. INterface BIOmaterials B.V. Description and Business Overview
Table 86. INterface BIOmaterials B.V. Embolization Particle Product
Table 87. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Product in 2024
Table 89. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Application in 2024
Table 90. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 91. INterface BIOmaterials B.V. Recent Developments
Table 92. Alicon Company Information
Table 93. Alicon Description and Business Overview
Table 94. Alicon Embolization Particle Product
Table 95. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Alicon Sales Proportion of Embolization Particle by Product in 2024
Table 97. Alicon Sales Proportion of Embolization Particle by Application in 2024
Table 98. Alicon Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 99. Alicon Recent Developments
Table 100. North America Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 101. North America Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 102. North America Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 105. North America Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 106. Asia-Pacific Embolization Particle Sales by Region (2020-2025) & (K Units)
Table 107. Asia-Pacific Embolization Particle Sales by Region (2026-2031) & (K Units)
Table 108. Asia-Pacific Embolization Particle Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Embolization Particle Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 111. Asia-Pacific Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 112. Europe Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 113. Europe Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 114. Europe Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 117. Europe Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 118. Latin America Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 119. Latin America Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 120. Latin America Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 123. Latin America Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 124. Middle East and Africa Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 125. Middle East and Africa Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 126. Middle East and Africa Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 129. Middle East and Africa Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 130. Embolization Particle Key Raw Materials, Industry Status and Trend
Table 131. Embolization Particle Key Raw Materials and Upstream Suppliers
Table 132. Embolization Particle Clients Status and Trend
Table 133. Embolization Particle Typical Clients
Table 134. Embolization Particle Distributors
Table 135. Embolization Particle Market Trends
Table 136. Embolization Particle Market Drivers
Table 137. Embolization Particle Market Challenges
Table 138. Embolization Particle Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Embolization Particle Product Picture
Figure 2. Global Embolization Particle Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Embolization Particle Sales Market Share by Type in 2024 & 2031
Figure 4. Microspheres Product Picture
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
Figure 6. Drug-eluting Beads (DEBs) Product Picture
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
Figure 8. Global Embolization Particle Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Embolization Particle Sales Market Share by Application in 2024 & 2031
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Others
Figure 15. Embolization Particle Report Years Considered
Figure 16. Global Embolization Particle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Embolization Particle Market Size 2020-2031 (US$ Million)
Figure 18. Global Embolization Particle Sales 2020-2031 (K Units)
Figure 19. Global Embolization Particle Sales Market Share Forecast by Region (2020-2031)
Figure 20. Global Embolization Particle Revenue Market Share by Region (2020-2031)
Figure 21. Global Embolization Particle Sales Market Share Forecast by Type (2020-2031)
Figure 22. Global Embolization Particle Revenue Market Share Forecast by Type (2020-2031)
Figure 23. Embolization Particle Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 24. Global Embolization Particle Sales Market Share Forecast by Application (2020-2031)
Figure 25. Global Embolization Particle Revenue Market Share Forecast by Application (2020-2031)
Figure 26. Embolization Particle Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 27. Microspheres of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 28. Particles (e.g. PVA Particles, Gelfoam Particles) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 29. Drug-eluting Beads (DEBs) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 30. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 31. Global Embolization Particle Sales Share by Manufacturer in 2024
Figure 32. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 33. Microspheres Market Sales Proportion by Manufacturer in 2024
Figure 34. Particles (e.g. PVA Particles, Gelfoam Particles) Market Sales Proportion by Manufacturer in 2024
Figure 35. Drug-eluting Beads (DEBs) Market Sales Proportion by Manufacturer in 2024
Figure 36. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Sales Proportion by Manufacturer in 2024
Figure 37. North America Embolization Particle Revenue 2020-2031 (US$ Million)
Figure 38. North America Embolization Particle Sales Market Share by Type (2020-2025)
Figure 39. North America Embolization Particle Sales Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Embolization Particle Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Embolization Particle Sales Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Embolization Particle Revenue Market Share by Region (2020-2031)
Figure 43. Asia-Pacific Embolization Particle Sales Market Share by Type (2020-2025)
Figure 44. Asia-Pacific Embolization Particle Sales Market Share by Application (2020-2025)
Figure 45. Europe Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Europe Embolization Particle Sales Market Share by Country (2020-2031)
Figure 47. Europe Embolization Particle Revenue Market Share by Country (2020-2031)
Figure 48. Europe Embolization Particle Sales Market Share by Type (2020-2025)
Figure 49. Europe Embolization Particle Sales Market Share by Application (2020-2025)
Figure 50. Latin America Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Embolization Particle Sales Market Share by Country (2020-2031)
Figure 52. Latin America Embolization Particle Revenue Market Share by Country (2020-2025)
Figure 53. Latin America Embolization Particle Sales Market Share by Type (2020-2025)
Figure 54. Latin America Embolization Particle Sales Market Share by Application (2020-2025)
Figure 55. Middle East and Africa Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Middle East and Africa Embolization Particle Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Embolization Particle Revenue Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Embolization Particle Sales Market Share by Type (2020-2025)
Figure 59. Middle East and Africa Embolization Particle Sales Market Share by Application (2020-2025)
Figure 60. Embolization Particle Supply Chain (Upstream and Downstream Market)
Figure 61. Global Production Market Share of Embolization Particle Raw Materials by Region in 2024
Figure 62. Embolization Particle Distribution Channels
Figure 63. Global Embolization Particle Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 64. Global Embolization Particle Percentage 2020-2031: Online Sales VS Offline Sales
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Embolization Particle Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Embolization Particle Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Embolization Particle Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Embolization Particle Sales by Region (2020-2025) & (K Units)
Table 5. Global Embolization Particle Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Embolization Particle Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Embolization Particle Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Embolization Particle Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Embolization Particle Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Embolization Particle Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Embolization Particle Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Embolization Particle Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Embolization Particle Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Embolization Particle Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Embolization Particle Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Embolization Particle Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Embolization Particle Sales Share by Manufacturer (2020-2025)
Table 18. Embolization Particle Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Embolization Particle Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Embolization Particle Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Embolization Particle Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Embolization Particle Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2024)
Table 24. Embolization Particle Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Embolization Particle Market
Table 26. Manufacturers Embolization Particle Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Sirtex Medical Company Information
Table 29. Sirtex Medical Description and Business Overview
Table 30. Sirtex Medical Embolization Particle Product
Table 31. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Sirtex Medical Sales Proportion of Embolization Particle by Product in 2024
Table 33. Sirtex Medical Sales Proportion of Embolization Particle by Application in 2024
Table 34. Sirtex Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 35. Sirtex Medical Recent Developments
Table 36. Merit Medical Company Information
Table 37. Merit Medical Description and Business Overview
Table 38. Merit Medical Embolization Particle Product
Table 39. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merit Medical Sales Proportion of Embolization Particle by Product in 2024
Table 41. Merit Medical Sales Proportion of Embolization Particle by Application in 2024
Table 42. Merit Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 43. Merit Medical Recent Developments
Table 44. Cook Medical Company Information
Table 45. Cook Medical Description and Business Overview
Table 46. Cook Medical Embolization Particle Product
Table 47. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Cook Medical Sales Proportion of Embolization Particle by Product in 2024
Table 49. Cook Medical Sales Proportion of Embolization Particle by Application in 2024
Table 50. Cook Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 51. Cook Medical Recent Developments
Table 52. BTG Medical Company Information
Table 53. BTG Medical Description and Business Overview
Table 54. BTG Medical Embolization Particle Product
Table 55. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. BTG Medical Sales Proportion of Embolization Particle by Product in 2024
Table 57. BTG Medical Sales Proportion of Embolization Particle by Application in 2024
Table 58. BTG Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 59. BTG Medical Recent Developments
Table 60. Boston Scientific Corporation Company Information
Table 61. Boston Scientific Corporation Description and Business Overview
Table 62. Boston Scientific Corporation Embolization Particle Product
Table 63. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Boston Scientific Corporation Sales Proportion of Embolization Particle by Product in 2024
Table 65. Boston Scientific Corporation Sales Proportion of Embolization Particle by Application in 2024
Table 66. Boston Scientific Corporation Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 67. Boston Scientific Corporation Recent Developments
Table 68. Terumo Corporation Company Information
Table 69. Terumo Corporation Description and Business Overview
Table 70. Terumo Corporation Embolization Particle Product
Table 71. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Terumo Corporation Sales Proportion of Embolization Particle by Product in 2024
Table 73. Terumo Corporation Sales Proportion of Embolization Particle by Application in 2024
Table 74. Terumo Corporation Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 75. Terumo Corporation Recent Developments
Table 76. HENGRUI Medical Company Information
Table 77. HENGRUI Medical Description and Business Overview
Table 78. HENGRUI Medical Embolization Particle Product
Table 79. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. HENGRUI Medical Sales Proportion of Embolization Particle by Product in 2024
Table 81. HENGRUI Medical Sales Proportion of Embolization Particle by Application in 2024
Table 82. HENGRUI Medical Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 83. HENGRUI Medical Recent Developments
Table 84. INterface BIOmaterials B.V. Company Information
Table 85. INterface BIOmaterials B.V. Description and Business Overview
Table 86. INterface BIOmaterials B.V. Embolization Particle Product
Table 87. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Product in 2024
Table 89. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Application in 2024
Table 90. INterface BIOmaterials B.V. Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 91. INterface BIOmaterials B.V. Recent Developments
Table 92. Alicon Company Information
Table 93. Alicon Description and Business Overview
Table 94. Alicon Embolization Particle Product
Table 95. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Alicon Sales Proportion of Embolization Particle by Product in 2024
Table 97. Alicon Sales Proportion of Embolization Particle by Application in 2024
Table 98. Alicon Sales Proportion of Embolization Particle by Geographic Area in 2024
Table 99. Alicon Recent Developments
Table 100. North America Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 101. North America Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 102. North America Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 105. North America Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 106. Asia-Pacific Embolization Particle Sales by Region (2020-2025) & (K Units)
Table 107. Asia-Pacific Embolization Particle Sales by Region (2026-2031) & (K Units)
Table 108. Asia-Pacific Embolization Particle Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Embolization Particle Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 111. Asia-Pacific Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 112. Europe Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 113. Europe Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 114. Europe Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 117. Europe Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 118. Latin America Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 119. Latin America Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 120. Latin America Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 123. Latin America Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 124. Middle East and Africa Embolization Particle Sales by Country (2020-2025) & (K Units)
Table 125. Middle East and Africa Embolization Particle Sales by Country (2026-2031) & (K Units)
Table 126. Middle East and Africa Embolization Particle Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Embolization Particle Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Embolization Particle Sales by Type (2020-2025) & (K Units)
Table 129. Middle East and Africa Embolization Particle Sales by Application (2020-2025) & (K Units)
Table 130. Embolization Particle Key Raw Materials, Industry Status and Trend
Table 131. Embolization Particle Key Raw Materials and Upstream Suppliers
Table 132. Embolization Particle Clients Status and Trend
Table 133. Embolization Particle Typical Clients
Table 134. Embolization Particle Distributors
Table 135. Embolization Particle Market Trends
Table 136. Embolization Particle Market Drivers
Table 137. Embolization Particle Market Challenges
Table 138. Embolization Particle Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Embolization Particle Product Picture
Figure 2. Global Embolization Particle Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Embolization Particle Sales Market Share by Type in 2024 & 2031
Figure 4. Microspheres Product Picture
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
Figure 6. Drug-eluting Beads (DEBs) Product Picture
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
Figure 8. Global Embolization Particle Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Embolization Particle Sales Market Share by Application in 2024 & 2031
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Others
Figure 15. Embolization Particle Report Years Considered
Figure 16. Global Embolization Particle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Embolization Particle Market Size 2020-2031 (US$ Million)
Figure 18. Global Embolization Particle Sales 2020-2031 (K Units)
Figure 19. Global Embolization Particle Sales Market Share Forecast by Region (2020-2031)
Figure 20. Global Embolization Particle Revenue Market Share by Region (2020-2031)
Figure 21. Global Embolization Particle Sales Market Share Forecast by Type (2020-2031)
Figure 22. Global Embolization Particle Revenue Market Share Forecast by Type (2020-2031)
Figure 23. Embolization Particle Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 24. Global Embolization Particle Sales Market Share Forecast by Application (2020-2031)
Figure 25. Global Embolization Particle Revenue Market Share Forecast by Application (2020-2031)
Figure 26. Embolization Particle Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 27. Microspheres of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 28. Particles (e.g. PVA Particles, Gelfoam Particles) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 29. Drug-eluting Beads (DEBs) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 30. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) of Embolization Particle Revenue Market Share by Application, 2024 VS 2031
Figure 31. Global Embolization Particle Sales Share by Manufacturer in 2024
Figure 32. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 33. Microspheres Market Sales Proportion by Manufacturer in 2024
Figure 34. Particles (e.g. PVA Particles, Gelfoam Particles) Market Sales Proportion by Manufacturer in 2024
Figure 35. Drug-eluting Beads (DEBs) Market Sales Proportion by Manufacturer in 2024
Figure 36. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Sales Proportion by Manufacturer in 2024
Figure 37. North America Embolization Particle Revenue 2020-2031 (US$ Million)
Figure 38. North America Embolization Particle Sales Market Share by Type (2020-2025)
Figure 39. North America Embolization Particle Sales Market Share by Application (2020-2025)
Figure 40. Asia-Pacific Embolization Particle Revenue 2020-2031 (US$ Million)
Figure 41. Asia-Pacific Embolization Particle Sales Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Embolization Particle Revenue Market Share by Region (2020-2031)
Figure 43. Asia-Pacific Embolization Particle Sales Market Share by Type (2020-2025)
Figure 44. Asia-Pacific Embolization Particle Sales Market Share by Application (2020-2025)
Figure 45. Europe Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Europe Embolization Particle Sales Market Share by Country (2020-2031)
Figure 47. Europe Embolization Particle Revenue Market Share by Country (2020-2031)
Figure 48. Europe Embolization Particle Sales Market Share by Type (2020-2025)
Figure 49. Europe Embolization Particle Sales Market Share by Application (2020-2025)
Figure 50. Latin America Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Latin America Embolization Particle Sales Market Share by Country (2020-2031)
Figure 52. Latin America Embolization Particle Revenue Market Share by Country (2020-2025)
Figure 53. Latin America Embolization Particle Sales Market Share by Type (2020-2025)
Figure 54. Latin America Embolization Particle Sales Market Share by Application (2020-2025)
Figure 55. Middle East and Africa Embolization Particle Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Middle East and Africa Embolization Particle Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Embolization Particle Revenue Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Embolization Particle Sales Market Share by Type (2020-2025)
Figure 59. Middle East and Africa Embolization Particle Sales Market Share by Application (2020-2025)
Figure 60. Embolization Particle Supply Chain (Upstream and Downstream Market)
Figure 61. Global Production Market Share of Embolization Particle Raw Materials by Region in 2024
Figure 62. Embolization Particle Distribution Channels
Figure 63. Global Embolization Particle Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 64. Global Embolization Particle Percentage 2020-2031: Online Sales VS Offline Sales
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232